What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Researchers of VHIR and IRBLleida validate the new antitumor agent ABTL0812 as a new therapeutic strategy to fight against endometrial cancer A phase 2 clinical trial is being conducted with 40 patients with endometrial cancer in top cancer centers in the State and France. News Dr. Juan Ángel Recio receives a grant from the Ramón Areces Foundation for a melanoma research project For his project "The role of p38 alpha in the development and progression of UV-induced melanoma". The amount granted was 129,371 euros. News Researchers at VHIR identify a new therapeutic tool based on microRNAs against a type of childhood cancer The results of the study provide a proof of concept of the usefulness of this type of therapeutic strategies for neuroblastoma and other types of childhood cancer. News March 31, World Colorectal Cancer Day VHIR and the Biomedical Research in Digestive Tract Tumors group want to raise awareness among the population about the importance of the early diagnosis of colorectal cancer. News Vall d'Hebron is the first center of the State that has a state-of-the-art analyzer to detect biomarkers more precisely The SIMOA HD-1 technology allows the detection of proteins with a sensitivity 1000 times higher than traditional immunological assays. News A day to advance in ADHD and its comorbidities The group of Psychiatry, Mental Health and Addictions of the VHIR has organized the day "Advancing ADHD and its comorbidities: European project CoCA (Comorbidities of ADHD)". News Auditory alterations and chronic otitis are related to the insertion of ventilation tubes in the ear and not to the degree of cleft palate The insertion of ventilation tubes has been the standard in the treatment of the palate, as well as the early surgery for the closure of the palate. This study raises a change in the approach of these patients. News Second mini-symposium on Cancer Research Omics Some of the topics highlighted were the use of genomic analysis for the detection of genes in colorectal cancer or the sequencing of tumors to find new therapeutic targets. News The MIMARK project selected to participate in the Health Horizons Conference Eva Colás of the Biomedical Research in Gynecology Group of the VHIR has been in charge of doing the "pitch" with which MIMARK has been finalist in the IMAGINE IF! contest held in Barcelona on the 5th of March. News The Leo Messi Foundation renews its collaboration with the VHIR for the research on childhood cancer The agreement helps to develop both database maintenance and support activities in the coordination of clinical trials in the Paediatric Oncology and Haematology Department of Vall d'Hebron. News Demonstrate for the first time in humans that the application of neuroprotective eye drops is useful in the treatment of diabetic retinopathy It is the first evidence in humans that eye drops can reach the retina and modulate the action of neurons, which will be a change in the therapeutic strategy. News Bufa la Bombolla to promote the investigation of primary immunodeficiencies in Vall d'Hebron, with Abacus and Barcelona PID Foundation Support research and help raise awareness about PIDs with the solidarity bubble jars that you can buy at Abacus stores and share videos and photos with the hashtag #BufaLaBombolla on social networks. News Sign up to Corre en Gran to boost ALS research A group of interns at the Brians 2 penitentiary center organizes the race Corre en Gran, which this year will allocate the money raised for research into Amyotrophic Lateral Sclerosis carried out at the VHIR News Female Talent in the VHIR We celebrate the International Women's Day reviewing the figures of women working in the VHIR and emphasizing the future creation of a commission to enhance the role of women in the research. News Established that the excessive accumulation of brain neuromelanin cause the Parkinson's disease With gene therapy they managed to reduce the intracellular neuromelanin levels below the pathological threshold thus preventing the appearance of symptomatology and neurodegeneration. News Vall d'Hebron leads the first International Vaccination Guide for human papilloma virus in high risk populations Recommendations based on different levels of evidence based on the risk of infection and pathology associated with HPV in the risk groups and also based on the available evidence on vaccines. News The Michael J. Fox Foundation will finance a research project on new drugs for Parkinson's disease The Michael J Fox Foundation for Parkinson's Research Foundation (MJFF) and the Silverstein Foundation for Parkinson's disease with GBA will fund a research project led by Dr. Marta Martínez from the VHIR. News A gene involved in ADHD could be related to addictive substance use The gene LPHN3, a genetic factor related to the attention deficit / hyperactivity disorder (ADHD) in kids and adults, is associated -for the first time- with a high risk of consuming addictive substances. News Vall d’Hebron is the first center of the State that successfully treats a patient in the presymptomatic phase of infantile spinal muscle atrophy Vall d'Hebron professionals have also participated in trials that have allowed the development of this innovative gene therapy News Brown adipose tissue could be a therapeutic target to treat type 2 diabetes and obesity The study shows that the MTERF4 protein is essential for mitochondrial function in brown adipose tissue. Pagination First page « Previous page ‹ … Page 75 Page 76 Current page 77 Page 78 Page 79 … Next page › Last page »
